Concurrent Investment Advisors LLC Raises Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Concurrent Investment Advisors LLC boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 12,145 shares of the medical equipment provider’s stock after purchasing an additional 2,272 shares during the period. Concurrent Investment Advisors LLC’s holdings in Intuitive Surgical were worth $6,339,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth approximately $26,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter valued at approximately $36,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the third quarter valued at approximately $38,000. Finally, DT Investment Partners LLC lifted its position in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.3 %

NASDAQ ISRG opened at $608.48 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $216.73 billion, a P/E ratio of 94.93, a P/E/G ratio of 5.74 and a beta of 1.39. The stock’s fifty day moving average price is $563.17 and its 200-day moving average price is $522.88.

Insider Transactions at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 6,348 shares of company stock valued at $3,587,582. Insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on ISRG shares. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Royal Bank of Canada boosted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. BTIG Research upped their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.